WO2012017128A2 - Composición a base de extracto de romero y vitamina e y sus aplicaciones - Google Patents

Composición a base de extracto de romero y vitamina e y sus aplicaciones Download PDF

Info

Publication number
WO2012017128A2
WO2012017128A2 PCT/ES2011/070586 ES2011070586W WO2012017128A2 WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
rosemary extract
composition based
menopause
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2011/070586
Other languages
English (en)
French (fr)
Other versions
WO2012017128A3 (es
WO2012017128A1 (es
Inventor
Enrique De Miguel Del Campo
Guillermo Reglero Rada
Carlota Largo Aramburu
Fornari Reale
Mónica RODRÍGUEZ GARCÍA-RISCO
Laura Jaime De Pablo
Susana Santoyo Diez
Francisco Javier SEÑORANS RODRÍGUEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Original Assignee
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autonoma de Madrid, Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz filed Critical Universidad Autonoma de Madrid
Publication of WO2012017128A2 publication Critical patent/WO2012017128A2/es
Publication of WO2012017128A1 publication Critical patent/WO2012017128A1/es
Publication of WO2012017128A3 publication Critical patent/WO2012017128A3/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La composicióncomprende un extracto de romero y vitamina E, y puede ser utilizada como suplemento nutricional así como en la elaboración de composiciones farmacéuticas para reducir los procesos inflamatorios y la peroxidación lipídica en general, y, en particular los asociados con la menopausia, así como para laprevención y/oeltratamientodelos efectosadversos de las radiaciones ionizantes.
PCT/ES2011/070586 2011-08-05 Composición a base de extracto de romero y vitamina e y sus aplicaciones Ceased WO2012017128A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031225A ES2374482B1 (es) 2010-08-05 2010-08-05 Composición para la reducción de síntomas asociados a la menopausia.
ESP201031225 2010-08-05

Publications (3)

Publication Number Publication Date
WO2012017128A2 true WO2012017128A2 (es) 2012-02-09
WO2012017128A1 WO2012017128A1 (es) 2012-02-09
WO2012017128A3 WO2012017128A3 (es) 2012-03-08

Family

ID=

Also Published As

Publication number Publication date
ES2374482A1 (es) 2012-02-17
WO2012017128A3 (es) 2012-03-08
ES2374482B1 (es) 2012-12-27

Similar Documents

Publication Publication Date Title
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2016086206A8 (en) Probiotic compositions containing clostridiales for inhibiting inflammation
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
WO2014179629A8 (en) Compositions and methods
HK1205942A1 (en) Compositions, methods, and kits for regulating energy metabolism
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
WO2014057362A3 (en) Omega -3 compositions
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
WO2013150386A3 (en) Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
WO2012049222A3 (en) Novel omega-3 and omega-6 fatty acid compositions and uses thereof
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2015067336A3 (en) Conjugated polymers
NZ716154A (en) Tricyclic benzoxaborole compound, preparation method therefor, and use thereof
HK1206621A1 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
HK1199841A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013100718A3 (ko) 라저스트로에미아 오바리폴리아 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 질환 또는 천식의 예방 또는 치료용 약학적 조성물
WO2010046458A3 (en) Compositions comprising vitamins
WO2012134172A3 (ko) 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 ｃ를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
WO2012017128A2 (es) Composición a base de extracto de romero y vitamina e y sus aplicaciones
WO2014031982A3 (en) Methods and compositions for treating pain
WO2012019010A3 (en) Antacid formulations and associated methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2